263 related articles for article (PubMed ID: 37451194)
1. The cross-talk between LncRNAs and JAK-STAT signaling pathway in cancer.
Hjazi A; Obaid RF; Ali SS; Abdullaev B; Alsaab HO; Huldani H; Romero-Parra RM; Mustafa YF; Hussien BM; Saadoon SJ
Pathol Res Pract; 2023 Aug; 248():154657. PubMed ID: 37451194
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA RP11-468E2.5 curtails colorectal cancer cell proliferation and stimulates apoptosis via the JAK/STAT signaling pathway by targeting STAT5 and STAT6.
Jiang L; Zhao XH; Mao YL; Wang JF; Zheng HJ; You QS
J Exp Clin Cancer Res; 2019 Nov; 38(1):465. PubMed ID: 31718693
[TBL] [Abstract][Full Text] [Related]
3. LncRNA BRCAT54 inhibits the tumorigenesis of non-small cell lung cancer by binding to RPS9 to transcriptionally regulate JAK-STAT and calcium pathway genes.
Yang W; Qian Y; Gao K; Zheng W; Wu G; He Q; Chen Q; Song Y; Wang L; Wang Y; Gu P; Chen B; Zhai R
Carcinogenesis; 2021 Feb; 42(1):80-92. PubMed ID: 32459848
[TBL] [Abstract][Full Text] [Related]
4. LINC01116 targets miR-520a-3p and affects IL6R to promote the proliferation and migration of osteosarcoma cells through the Jak-stat signaling pathway.
Zhang B; Yu L; Han N; Hu Z; Wang S; Ding L; Jiang J
Biomed Pharmacother; 2018 Nov; 107():270-282. PubMed ID: 30098545
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNAs and JAK/STAT signaling pathway regulation in colorectal cancer development.
Ghasemian A; Omear HA; Mansoori Y; Mansouri P; Deng X; Darbeheshti F; Zarenezhad E; Kohansal M; Pezeshki B; Wang Z; Tang H
Front Genet; 2023; 14():1297093. PubMed ID: 38094755
[TBL] [Abstract][Full Text] [Related]
6. The relationship between microRNAs and the STAT3-related signaling pathway in cancer.
Zhang L; Li J; Wang Q; Meng G; Lv X; Zhou H; Li W; Zhang J
Tumour Biol; 2017 Jul; 39(7):1010428317719869. PubMed ID: 28859543
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor-I receptor signal transduction and the Janus Kinase/Signal Transducer and Activator of Transcription (JAK-STAT) pathway.
Himpe E; Kooijman R
Biofactors; 2009; 35(1):76-81. PubMed ID: 19319849
[TBL] [Abstract][Full Text] [Related]
8. LncRNA IGFBP4-1 promotes tumor development by activating Janus kinase-signal transducer and activator of transcription pathway in bladder urothelial carcinoma.
Li C; Cao Y; Zhang L; Li J; Wu H; Ling F; Zheng J; Wang J; Li B; He J; Xie X; Li Z; Chen Y; He X; Guo M; Wei H; Ye J; Guo Y; Zhang S; Liu L; Liu G; Liu C
Int J Biol Sci; 2020; 16(13):2271-2282. PubMed ID: 32760196
[TBL] [Abstract][Full Text] [Related]
9. The JAK/STAT signaling pathway: from bench to clinic.
Hu X; Li J; Fu M; Zhao X; Wang W
Signal Transduct Target Ther; 2021 Nov; 6(1):402. PubMed ID: 34824210
[TBL] [Abstract][Full Text] [Related]
10. Targeting the JAK-STAT pathway in autoimmune diseases and cancers: A focus on molecular mechanisms and therapeutic potential.
Tzeng HT; Chyuan IT; Lai JH
Biochem Pharmacol; 2021 Nov; 193():114760. PubMed ID: 34492272
[TBL] [Abstract][Full Text] [Related]
11. Drosophila Jak/STAT Signaling: Regulation and Relevance in Human Cancer and Metastasis.
Trivedi S; Starz-Gaiano M
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30558204
[TBL] [Abstract][Full Text] [Related]
12. JAK-STAT signaling in cancer: From cytokines to non-coding genome.
Pencik J; Pham HT; Schmoellerl J; Javaheri T; Schlederer M; Culig Z; Merkel O; Moriggl R; Grebien F; Kenner L
Cytokine; 2016 Nov; 87():26-36. PubMed ID: 27349799
[TBL] [Abstract][Full Text] [Related]
13. Differential long noncoding RNA/mRNA expression profiling and functional network analysis during osteogenic differentiation of human bone marrow mesenchymal stem cells.
Zhang W; Dong R; Diao S; Du J; Fan Z; Wang F
Stem Cell Res Ther; 2017 Feb; 8(1):30. PubMed ID: 28173844
[TBL] [Abstract][Full Text] [Related]
14. LncRNA-135528 inhibits tumor progression by up-regulating CXCL10 through the JAK/STAT pathway.
Wang P; Peng X; Zhang J; Wang Z; Meng J; Cen B; Ji A; He S
Apoptosis; 2018 Dec; 23(11-12):651-666. PubMed ID: 30232656
[TBL] [Abstract][Full Text] [Related]
15. The Role of JAK/STAT Pathway in Fibrotic Diseases: Molecular and Cellular Mechanisms.
Liu J; Wang F; Luo F
Biomolecules; 2023 Jan; 13(1):. PubMed ID: 36671504
[TBL] [Abstract][Full Text] [Related]
16. JAK/STAT of all trades: linking inflammation with cancer development, tumor progression and therapy resistance.
Sabaawy HE; Ryan BM; Khiabanian H; Pine SR
Carcinogenesis; 2021 Dec; 42(12):1411-1419. PubMed ID: 34415330
[TBL] [Abstract][Full Text] [Related]
17. Mining for JAK-STAT mutations in cancer.
Constantinescu SN; Girardot M; Pecquet C
Trends Biochem Sci; 2008 Mar; 33(3):122-31. PubMed ID: 18291658
[TBL] [Abstract][Full Text] [Related]
18. Jak Stat signaling and cancer: Opportunities, benefits and side effects of targeted inhibition.
Groner B; von Manstein V
Mol Cell Endocrinol; 2017 Aug; 451():1-14. PubMed ID: 28576744
[TBL] [Abstract][Full Text] [Related]
19. An immunoevasive strategy through clinically-relevant pan-cancer genomic and transcriptomic alterations of JAK-STAT signaling components.
Chang WH; Lai AG
Mol Med; 2019 Nov; 25(1):46. PubMed ID: 31684858
[TBL] [Abstract][Full Text] [Related]
20. Organogenesis and tumorigenesis: insight from the JAK/STAT pathway in the Drosophila eye.
Wang YH; Huang ML
Dev Dyn; 2010 Oct; 239(10):2522-33. PubMed ID: 20737505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]